» Articles » PMID: 29856551

Lack of Evidence to Favor Specific Preventive Interventions in Psychosis: a Network Meta-analysis

Overview
Specialty Psychiatry
Date 2018 Jun 2
PMID 29856551
Citations 99
Authors
Affiliations
Soon will be listed here.
Abstract

Preventing psychosis in patients at clinical high risk may be a promising avenue for pre-emptively ameliorating outcomes of the most severe psychiatric disorder. However, information on how each preventive intervention fares against other currently available treatment options remains unavailable. The aim of the current study was to quantify the consistency and magnitude of effects of specific preventive interventions for psychosis, comparing different treatments in a network meta-analysis. PsycINFO, Web of Science, Cochrane Central Register of Controlled Trials, and unpublished/grey literature were searched up to July 18, 2017, to identify randomized controlled trials conducted in individuals at clinical high risk for psychosis, comparing different types of intervention and reporting transition to psychosis. Two reviewers independently extracted data. Data were synthesized using network meta-analyses. The primary outcome was transition to psychosis at different time points and the secondary outcome was treatment acceptability (dropout due to any cause). Effect sizes were reported as odds ratios and 95% confidence intervals (CIs). Sixteen studies (2,035 patients, 57% male, mean age 20.1 years) reported on risk of transition. The treatments tested were needs-based interventions (NBI); omega-3 + NBI; ziprasidone + NBI; olanzapine + NBI; aripiprazole + NBI; integrated psychological interventions; family therapy + NBI; D-serine + NBI; cognitive behavioural therapy, French & Morrison protocol (CBT-F) + NBI; CBT-F + risperidone + NBI; and cognitive behavioural therapy, van der Gaag protocol (CBT-V) + CBT-F + NBI. The network meta-analysis showed no evidence of significantly superior efficacy of any one intervention over the others at 6 and 12 months (insufficient data were available after 12 months). Similarly, there was no evidence for intervention differences in acceptability at either time point. Tests for inconsistency were non-significant and sensitivity analyses controlling for different clustering of interventions and biases did not materially affect the interpretation of the results. In summary, this study indicates that, to date, there is no evidence that any specific intervention is particularly effective over the others in preventing transition to psychosis. Further experimental research is needed.

Citing Articles

Preventing psychosis in people at clinical high risk: an updated meta-analysis by the World Psychiatric Association Preventive Psychiatry section.

Minichino A, Davies C, Karpenko O, Christodoulou N, Ramalho R, Nandha S Mol Psychiatry. 2025; .

PMID: 39953286 DOI: 10.1038/s41380-025-02902-8.


The Endocannabinoid Activity Remodulation for Psychosis Liability in Youth (EARLY) Study: An Open-Label Feasibility Trial of Ultramicronized-Palmitoylethanolamide Oral Supplementation in Clinical High-Risk State for Psychosis.

Bortoletto R, Garzitto M, Piscitelli F, Fornasaro S, Scipioni C, Sepulcri O Brain Sci. 2025; 14(12.

PMID: 39766429 PMC: 11727594. DOI: 10.3390/brainsci14121230.


Review: Efficacy of preventative interventions for children and adolescents at clinical high risk of psychosis - a systematic review and meta-analysis of intervention studies.

Frearson G, de Otazu Olivares J, Catalan A, Aymerich C, Salazar de Pablo G Child Adolesc Ment Health. 2024; 30(1):66-82.

PMID: 39688301 PMC: 11754713. DOI: 10.1111/camh.12755.


Clinical and functional outcomes at 7-year follow-up of children presenting putative antecedents of schizophrenia at age 9-12 years.

Cullen A, Roberts R, Fisher H, Laurens K Schizophrenia (Heidelb). 2024; 10(1):83.

PMID: 39349507 PMC: 11442655. DOI: 10.1038/s41537-024-00507-8.


Ethical challenges in contemporary psychiatry: an overview and an appraisal of possible strategies and research needs.

Galderisi S, Appelbaum P, Gill N, Gooding P, Herrman H, Melillo A World Psychiatry. 2024; 23(3):364-386.

PMID: 39279422 PMC: 11403198. DOI: 10.1002/wps.21230.


References
1.
Bechdolf A, Phillips L, Francey S, Leicester S, Morrison A, Veith V . Recent approaches to psychological interventions for people at risk of psychosis. Eur Arch Psychiatry Clin Neurosci. 2006; 256(3):159-73. DOI: 10.1007/s00406-006-0623-0. View

2.
Wilson R, Patel R, Bhattacharyya S . Do fewer males present to clinical high-risk services for psychosis relative to first-episode services?. Early Interv Psychiatry. 2016; 11(5):429-435. DOI: 10.1111/eip.12311. View

3.
Higgins J, Altman D, Gotzsche P, Juni P, Moher D, Oxman A . The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011; 343:d5928. PMC: 3196245. DOI: 10.1136/bmj.d5928. View

4.
McGorry P, Nelson B, Phillips L, Yuen H, Francey S, Thampi A . Randomized controlled trial of interventions for young people at ultra-high risk of psychosis: twelve-month outcome. J Clin Psychiatry. 2012; 74(4):349-56. DOI: 10.4088/JCP.12m07785. View

5.
Fusar-Poli P, Cappucciati M, Rutigliano G, Lee T, Beverly Q, Bonoldi I . Towards a Standard Psychometric Diagnostic Interview for Subjects at Ultra High Risk of Psychosis: CAARMS versus SIPS. Psychiatry J. 2016; 2016:7146341. PMC: 4904115. DOI: 10.1155/2016/7146341. View